Rockwell Medical (RMTI) Gross Profit (2010 - 2026)

Rockwell Medical's Gross Profit history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• Quarterly Gross Profit fell 4.77% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (down 33.86% YoY) and the FY2025 annual result came in at $11.7 million, down 33.11% from the prior year.
• Gross Profit was $2.9 million for Q1 2026 at Rockwell Medical, down from $3.9 million in the prior quarter.
• Across five years, Gross Profit topped out at $6.2 million in Q3 2024 and bottomed at -$786000.0 in Q1 2022.
• A 5-year average of $2.6 million and a median of $2.6 million in 2023 frame the typical range for Gross Profit.
• Peak annual rise in Gross Profit reached 766.03% in 2022, while the deepest fall reached 296.01% in 2022.
• Rockwell Medical's Gross Profit stood at $2.3 million in 2022, then grew by 22.65% to $2.9 million in 2023, then increased by 26.52% to $3.6 million in 2024, then climbed by 6.8% to $3.9 million in 2025, then dropped by 25.3% to $2.9 million in 2026.
• Business Quant data shows RMTI's Gross Profit at $2.9 million in Q1 2026, $3.9 million in Q4 2025, and $2.3 million in Q3 2025.